Mia's Feed
Medical News & Research

Artificial Intelligence Enhances Speed and Precision in Autism and ADHD Diagnosis

Artificial Intelligence Enhances Speed and Precision in Autism and ADHD Diagnosis

Share this article

Innovative AI techniques are accelerating and improving the accuracy of autism and ADHD diagnoses through quantitative biomarker analysis, enabling faster assessments and personalized treatment planning.

2 min read

Recent advancements in artificial intelligence (AI) are revolutionizing the diagnosis process for neurodivergent conditions such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). Traditionally, diagnosing these disorders can take up to 18 months due to the reliance on subjective assessments, clinical interviews, and behavioral surveys, which often lack standardized biological markers.

A groundbreaking study led by researchers at Indiana University introduces a data-driven approach that leverages AI to identify quantifiable biomarkers and biometric data, significantly reducing diagnostic time to approximately 15 minutes. This innovative method involves analyzing minute movement patterns with sensors attached to participants' hands while performing simple reaching tasks. These sensors capture high-definition kinematic data, including acceleration, rotation, and linear movements, which reveal subtle differences in motor control between neurotypical individuals and those with ASD or ADHD.

The research builds on earlier work from 2018, where the team discovered movement biomarkers imperceptible to the naked eye but measurable with sensors. Using advanced deep learning algorithms, they assessed movement irregularities that correlate with the severity of neurodivergent disorders. This approach offers a new set of objective biomarkers, enabling clinicians to evaluate how serious a condition is and monitor treatment effectiveness.

While the AI-powered diagnostics are designed to augment, not replace, professional clinical assessments, they could serve as valuable tools for early screening and triage in educational and clinical settings. For example, schools could utilize this technology to identify students who may need further evaluation and intervention, facilitating earlier support and care.

The development of these quantitative tools aims to provide a more standardized and reliable method for diagnosing autism and ADHD, ultimately leading to more personalized and effective treatments. By quantifying movement irregularities and employing deep learning, healthcare providers can better understand the severity of neurodivergent conditions and tailor interventions accordingly.

For more details, refer to the original study published in Scientific Reports: Khoshrav P. Doctor et al, Deep learning diagnosis plus kinematic severity assessments of neurodivergent disorders, 2025.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

States Prepare for Potential Reversal of Obamacare Coverage Improvements Under New Federal Legislation

State governments and healthcare experts warn that recent federal legislation could reverse years of progress in health insurance coverage, increasing premiums and reducing access for millions of Americans under the ACA.

Obesity and Physical Activity as Factors Influencing Cancer Risk in Childhood Cancer Survivors

A recent study reveals that body weight and physical activity significantly influence the risk of secondary cancers in childhood cancer survivors, emphasizing the importance of lifestyle management in long-term survivorship care.

Enhancing Cancer Outcomes Through Improved Lynch Syndrome Testing: A Cost-Effectiveness Analysis

A comprehensive analysis demonstrates that universal Lynch syndrome testing for colorectal cancer patients significantly enhances early detection and is cost-effective, leading to improved cancer prevention and reduced healthcare costs.

Innovative Weekly Injectable Treatment Could Replace Daily Pills for Parkinson's Patients

Scientists have developed a weekly injectable treatment promising to replace daily pills for Parkinson's disease, potentially transforming management and improving patients' quality of life.